Drug Overview: Epogen

Drug Overview: Epogen

  • January 2018 •
  • 27 pages •
  • Report ID: 5391393 •
  • Format: PDF
Drug Overview
Epogen (epoetin alfa; Amgen/Kyowa Hakko Kirin/Johnson&Johnson) is an erythropoiesis-stimulating agent administered by intravenous or subcutaneous injection, and is indicated for the treatment of anemia in chronic kidney disease and chemotherapy-induced anemia. The drug consists of recombinant human erythropoietin and targets the erythropoietin receptor, initiating the same pathway as native erythropoietin and triggering increased blood production in bone marrow.